Navigation Links
Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepatitis C Infections
Date:4/15/2013

SYDNEY, April 15, 2013 /PRNewswire/ -- RNAi-based therapeutics company Benitec Biopharma Limited (ASX Code: BLT) today announced the selection of the University of California, San Diego (UCSD), Health Sciences as the second site for its upcoming phase I/II first-in-man trial for TT-034 in Hepatitis C infections (HCV). Benitec previously announced the selection of Duke Clinical Research Unit as the other site. TT-034 is being developed as a potential "one-shot-cure" for HCV.

A consultant and sub-principal investigator for the study from UCSD Health Sciences will be Robert Gish , M.D., clinical professor of Medicine and medical director of Hepatology. Dr. Gish is a renowned hepatitis researcher with previous experience using RNAi based therapeutics for HCV. He has over 500 publications in the field and is a fellow of the American College of Physicians and the American Association for the Study of Liver Disease.

"I look forward to working with Benitec and Duke University on this important program," Dr. Gish commented. "This is the first time that this therapeutic modality is being tested in humans, and if it is successful I believe it can be a significant step forward, not only for HCV treatment but potentially also as a treatment modality for Hepatitis B."

The principal investigator for the study at UC San Diego is David Wyles , M.D., associate professor of Medicine at the UC San Diego AntiViral Research Center, the clinical research site that will be conducting the trial. His research interests include the laboratory evaluation of new antiviral therapies for HCV, drug resistance to HCV antivirals, and HCV viral fitness.

Peter French , Ph.D., chief executive officer of Benitec said, "We are elated that UC San Diego and Dr. Gish will participate in this study.  We now have two top clinical research teams working with
'/>"/>

SOURCE Benitec Biopharma Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Appointment of Mr. Kevin Buchi to Benitec Board
2. Medical University of South Carolina Selects Elseviers Interdisciplinary Care Planning and Clinical Documentation Solution
3. Greenwood Genetic Center Selects Cartagenia BENCHlab NGS, CNV Solutions for Clinical Data Analysis
4. New York Genome Institute Selects Exemplar LIMS to Manage Next Gen Sequencing Labs
5. Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry
6. The Genome Analysis Center Selects Convey to Support Next-Generation Sequencing
7. MC Leeuwarden Selects ClinicalKey
8. Providence Health & Services Selects Conflict of Interest Management System
9. Shield Therapeutics Selects OpenClinica Enterprise
10. University of College London Hospitals (UCLH) Selects GEO SCAN Medical as New Standard of Care for the Detection and Treatment of Prostate Cancer
11. Moscow State University Hospital Selects Ekahau RTLS to Improve Operations and Patient Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... Standard Networks announced Tuesday a new platform-independent Java ... MOVEit DMZ servers over firewall-friendly HTTPS encrypted connections. , ... for specific platforms, including a Windows API and a ... and secure FTP access. , ,The Java offering is ...
... the Midwest Tel Net consortium have selected Occam ... and high-speed data to the companies' rural residential and ... are Hillsboro Telephone Co. Inc., LaValle Telephone Cooperative and ... was the first local carrier in Wisconsin to ...
... University's new "living laboratory" of teaching technology will ... Madison-based Sonic Foundry, Inc. , to automatically ... company announced Monday. , ,The laboratory, termed the ... with data for making informed investment decisions across ...
Cached Biology Technology:Three Midwest Tel Net members select Occam's platform to increase service 2Ohio State's educational tech lab to use Sonic Foundry system 2
(Date:4/15/2014)... Miami could know as early as 2020 how high ... to a team of researchers including Florida International University ... the National Science Foundation,s (NSF) Florida Coastal Everglades Long-Term ... LTER sites in ecosystems from coral reefs to deserts, ... conclude that sea level rise is one of the ...
(Date:4/15/2014)... UC San Diego have succeeded in visualizing the ... for growth and resistance to drought. The achievement ... determine how the hormone helps plants respond to ... continuing increase in the atmosphere,s carbon dioxide, or ... in the April 15 issue of the scientific ...
(Date:4/15/2014)... found a less invasive way to extract single ... how the mouth,s natural defenses ward off infection ... cells (white blood cells known as "leukocytes") to ... reject foreign tissues, such as in failed organ ... preventing such health issues as oral cancers, cardiovascular ...
Breaking Biology News(10 mins):Long-term predictions for Miami sea level rise could be available relatively soon 2Biologists develop nanosensors to visualize movements and distribution of plant hormone 2New method isolates immune cells for researchers to study how they ward off oral diseases 2
... Foundation announced that it will provide $200,000 in 2009 to ... treatment for Rett Syndrome. The study will be carried ... Boston Children,s Hospital, led by Dr. Omar Khwaja MD, PhD ... to be tested in Rett syndrome patients. Investigators will ...
... 2009 CryoLife, Inc. (NYSE: CRY) Elite cardiovascular surgeons ... week for the two-day Ross Summit to review and discuss ... Ross Procedure and to practice the technical nuances required to ... is a type of specialized aortic valve surgery in which ...
... 21, 2009 -- Investigators at Burnham Institute for ... for the enzyme caspase-3 (an enzyme that proteolytically ... called N-terminomics, Guy Salvesen, Ph.D., professor and director ... of Burnham,s NCI-designated Cancer Center, and colleagues determined ...
Cached Biology News:IRSF announces funding of first clinical trial with disease-modifying therapy for Rett syndrome 2Growing outcomes evidence spurs renewed interest in unique heart valve procedure 2How proteins talk to each other 2
Sheep polyclonal to Salmonella Shoreditch ( Abpromise for all tested applications). Antigen: Native Salmonella shoreditch (Group D2)....
Rabbit polyclonal to ZA20D3 ( Abpromise for all tested applications). entrezGeneID: 54469 SwissProtID: Q6FIF0...
... Rabbit polyclonal to Oct6 ( Abpromise ... Synthetic peptide conjugated to KLH derived from ... (Note: the amino acid sequence is proprietary) ... .) Entrez Gene ID: ...
ATP-binding cassette sub-family D member 4 (Peroxisomal membrane protein 69) (PMP69) (Peroxisomal membrane protein 1-like) (PXMP1-L) (P70R). [Source:Uniprot/SWISSPROT;Acc:O14678] Antigen: Recombi...
Biology Products: